Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ACOR Financial Statements and Analysis

NASDAQ : ACOR

Acorda Therapeutics, Inc.

$0.66
-0.209-24.02%
Open: 4:00 PM
Not Actively Trading
66.74
BESG ScoreESG Rating

ACOR FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ACOR Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-03-312023-12-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
revenue20.289M37.985M27.715M29.675M22.258M
cost of revenue3.707M13.289M3.387M3.065M3.234M
gross profit16.582M24.696M24.328M26.61M19.024M
gross profit ratio0.8170.650.8780.8970.855
research and development expenses954.00K1.009M1.207M1.55M1.386M
general and administrative expenses00021.825M0
selling and marketing expenses00000
selling general and administrative expenses28.371M22.206M23.152M21.825M22.514M
other expenses11.00K-158.00K403.00K1.00K7.691M
operating expenses29.969M23.215M32.05M31.066M31.591M
cost and expenses33.676M36.504M35.437M34.131M34.825M
interest income207.00K222.00K157.00K58.00K93.00K
interest expense8.057M9.20M7.827M7.715M7.571M
depreciation and amortization882.00K7.923M7.691M7.691M8.098M
ebitda-12.666M9.404M372.00K3.236M-4.469M
ebitda ratio-0.6240.2480.0130.109-0.201
operating income-19.628M1.481M-2.519M-3.632M-12.567M
operating income ratio-0.9670.039-0.091-0.122-0.565
total other income expenses net-5.244M-257.351M5.606M825.00K-6.295M
income before tax-27.281M-255.87M-9.943M-11.346M-18.862M
income before tax ratio-1.345-6.736-0.359-0.382-0.847
income tax expense114.00K-38.109M-1.055M-1.965M-2.038M
net income-27.395M-217.761M-8.888M-9.381M-16.824M
net income ratio-1.35-5.733-0.321-0.316-0.756
eps-22.06-225.81-7.16-7.55-13.83
eps diluted-22.06-225.81-7.16-7.55-13.83
weighted average shs out1.242M964.376K1.242M1.242M1.217M
weighted average shs out dil1.242M964.376K1.242M1.242M1.217M
Graph

ACOR Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-03-312023-12-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
cash and cash equivalents9.364M30.36M32.468M25.27M30.255M
short term investments00000
cash and short term investments9.364M30.36M32.468M25.27M30.255M
net receivables9.188M17.298M11.977M13.39M9.19M
inventory14.119M16.155M17.942M14.797M13.465M
other current assets15.782M10.981M10.48M10.629M4.07M
total current assets48.453M74.794M73.728M64.914M68.094M
property plant equipment net5.834M6.30M6.706M6.928M7.412M
goodwill00000
intangible assets22.343M22.987M282.006M289.70M297.393M
goodwill and intangible assets22.343M22.987M282.006M289.70M297.393M
long term investments0255.00K255.00K255.00K510.00K
tax assets09.22M-255.00K-255.00K-510.00K
other non current assets4.945M4.189M3.904M3.154M2.007M
total non current assets33.122M42.951M292.616M299.782M306.812M
other assets00000
total assets81.575M117.745M366.344M364.696M374.906M
account payables9.932M13.373M12.33M3.175M2.854M
short term debt193.073M187.731M1.578M1.567M1.556M
tax payables00000
deferred revenue294.00K227.00K465.00K548.00K0
other current liabilities20.637M26.442M31.921M25.095M30.329M
total current liabilities223.936M227.773M46.294M30.385M34.739M
long term debt2.847M3.166M184.511M179.928M175.551M
deferred revenue non current00000
deferred tax liabilities non current09.22M38.544M39.556M41.805M
other non current liabilities40.563M35.542M38.038M46.959M45.851M
total non current liabilities43.41M47.928M261.093M266.443M263.207M
other liabilities00000
capital lease obligations4.446M3.166M5.046M5.331M5.611M
total liabilities267.346M275.701M307.387M296.828M297.946M
preferred stock000961.597M0
common stock1.00K1.00K1.00K1.00K24.00K
retained earnings-1.217B-1.189B-971.366M-962.478M-953.097M
accumulated other comprehensive income loss875.00K1.425M717.00K880.00K719.00K
other total stockholders equity1.03B1.03B1.03B67.868M1.029B
total stockholders equity-185.771M-157.956M58.957M67.868M76.96M
total equity-185.771M-157.956M58.957M67.868M76.96M
total liabilities and stockholders equity81.575M117.745M366.344M364.696M374.906M
minority interest00000
total investments0255.00K255.00K255.00K510.00K
total debt195.92M190.897M186.089M181.495M177.107M
net debt186.556M160.537M153.621M156.225M146.852M
Graph

ACOR Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-03-312023-12-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
deferred income tax0-38.156M-1.018M-1.965M-2.038M
stock based compensation130.00K138.00K141.00K128.00K71.00K
change in working capital-5.374M-9.052M9.797M-12.062M486.00K
accounts receivables8.11M-5.321M1.469M-4.268M4.688M
inventory2.036M1.786M-3.144M-1.332M-713.00K
accounts payables-10.26M-5.456M16.097M-5.081M-4.676M
other working capital0-61.00K-4.625M-1.381M701.00K
other non cash items11.572M253.89M-341.00K3.811M3.374M
net cash provided by operating activities-20.185M-3.018M7.608M-11.556M-7.018M
investments in property plant and equipment0-44.00K-220.00K00
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites0-44.00K-220.00K00
debt repayment00000
common stock issued00000
common stock repurchased00000
dividends paid00000
other financing activites00000
net cash used provided by financing activities00-6.884M00
effect of forex changes on cash-93.00K93.00K-157.00K155.00K97.00K
net change in cash-20.278M-2.969M7.231M-11.401M-6.921M
cash at end of period10.337M30.36M33.584M26.353M37.754M
cash at beginning of period30.615M33.329M26.353M37.754M44.675M
operating cashflow-20.185M-3.018M7.608M-11.556M-7.018M
capital expenditure0-44.00K-220.00K00
free cash flow-20.185M-3.062M7.388M-11.556M-7.018M
Graph

Frequently Asked Questions

How did Acorda Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ACOR generated $20.29M in revenue last quarter, while its costs came in at $3.71M.

Last quarter, how much Gross Profit did Acorda Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Acorda Therapeutics, Inc. reported a $16.58M Gross Profit for the quarter ended Mar 31, 2024.

Have ACOR's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ACOR incurred $29.97M worth of Operating Expenses, while it generated -$19.63M worth of Operating Income.

How much Net Income has ACOR posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Acorda Therapeutics, Inc., the company generated -$27.40M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Acorda Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Acorda Therapeutics, Inc. as of the end of the last quarter was $9.36M.

What are ACOR's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ACOR had Total Net Receivables of $9.19M.

In terms of Total Assets and Current Assets, where did Acorda Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ACOR were $48.45M, while the Total Assets stand at $81.58M.

As of the last quarter, how much Total Debt did Acorda Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ACOR's debt was $195.92M at the end of the last quarter.

What were ACOR's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ACOR reported total liabilities of $267.35M.

How much did ACOR's Working Capital change over the last quarter?

Working Capital Change for ACOR was -$5.37M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ACOR generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ACOR generated -$20.19M of Cash from Operating Activities during its recently reported quarter.

What was ACOR's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ACOR reported a -$20.28M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph